Clinical trial

Isolation of Circulating Pulmonary Cells in COPD and Its Relationship With Clinical Relevant Outcomes (IbICEnCa)

NCT03591978

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention Isolation of Circulating Pulmonary Cells in peripheral blood Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Isolation of Circulating Pulmonary Cells in COPD and Its Relationship With Clinical Relevant Outcomes (IbICEnCa)

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2019-05-01

PhaseN/A

Conditions

COPDverified · MONDO: chronic obstructive pulmonary disease

COPD Exacerbationunresolved

COPD, Severe Early-Onsetverified · MONDO: COPD, severe early onset

Interventions

Isolation of Circulating Pulmonary Cells in peripheral bloodDIAGNOSTIC_TEST

Sponsors & collaborators

Universidad de Granadalead sponsor

Hospital de Alta Resolucion de Loja. Agencia Sanitaria Hospital de Ponientecollaborator

Junta de Andaluciacollaborator

Mapped research locations

GranadaSpain2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03591978 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.